Global Head and Vice President of Early Clinical Development

I am a translational medicine scientist with expertise in cardiovascular pharmacotherapy and quantitative clinical pharmacology. I am a Fellow of the American College of Cardiology (FACC) and the European Society of Cardiology (FESC). My work spans early clinical development, integrating PK/PD, physiologically based pharmacokinetic modeling, and model-informed dosing to translate mechanistic insights into safe and effective cardiovascular therapies, including antithrombotic and cardiomyopathy programs.